Humacyte Inc (HUMA)
2.31 x 3 2.32 x 2
Post-market by (Cboe BZX)
2.88 -0.44 (-13.40%) 03/25/25 [NASDAQ]
2.31 x 3 2.32 x 2
Post-market 2.31 -0.56 (-19.65%) 17:16 ET
for Tue, Mar 25th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
Operating Expenses | 30,233 | 29,499 | 26,578 | 26,182 | 24,622 |
Operating Income | -30,233 | -29,499 | -26,578 | -26,182 | -24,622 |
Interest Expense | 2,438 | 2,515 | 1,816 | 1,727 | 1,463 |
Other Income | -6,531 | -24,649 | -3,502 | 2,803 | 90 |
Pre-tax Income | -39,202 | -56,663 | -31,896 | -25,106 | -25,995 |
Net Income Continuous | -39,202 | -56,663 | -31,896 | -25,106 | -25,995 |
Net Income | $-39,202 | $-56,663 | $-31,896 | $-25,106 | $-25,995 |
EPS Basic Total Ops | -0.33 | -0.48 | -0.29 | -0.24 | -0.25 |
EPS Basic Continuous Ops | -0.33 | -0.48 | -0.29 | -0.24 | -0.25 |
EPS Diluted Total Ops | -0.33 | -0.48 | -0.29 | -0.24 | -0.25 |
EPS Diluted Continuous Ops | -0.33 | -0.48 | -0.29 | -0.24 | -0.25 |
EPS Diluted Before Non-Recurring Items | -0.33 | -0.27 | -0.29 | -0.24 | -0.25 |
EBITDA(a) | $-28,421 | $-27,720 | $-24,787 | $-24,349 | $-22,792 |